Drug Patent Expirations for February 2016
Tradename
Applicant
Generic Name
Patent Number
Patent Expiration
ELOXATIN
Sanofi Aventis Us
oxaliplatin
5,716,988*PED
Feb 7, 2016
JUXTAPID
Aegerion
lomitapide mesylate
5,712,279
Feb 21, 2016
ARNUITY ELLIPTA…
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Legal and regulatory update
Go to paperABSTRACT: The Office of Fair Trading (OFT) has recently found Genzyme Limited guilty of abusing its dominant posi…
DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. ELOXATIN (oxaliplatin) Sanofi Aventis Us Patent number: 5,716,988 Expiration Date: Feb 7, 2016 For more information try a free trial
DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. NUEDEXTA (dextromethorphan hydrobromide; quinidine sulfate) Avanir Pharms Patent number: RE 38,115 Expiration Date: Jan 26, 2016 UTIBRON (glycopyrrolate ; indacaterol maleate) Novartis Pharms Corp Patent number: 6,521,260 Expiration […]
Make in India recently published an advertorial in the Washington Post proclaiming that “2016 is India’s Growth Year For Pharma.” I don’t doubt that India has growth potential, as it ranks 51st out of 54 nations that I compare in the Scientific American Worldview scorecard. The problem with Make in India’s encouraging proclamation is that […]
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Understanding ‘science and the public’
Go to paperABSTRACT: Public acceptance of the products of biotechnology is an important issue for the industry. T…
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Festo: The plague continues
Go to paperABSTRACT: This paper reviews the law on the doctrine of equivalence and prosecution history estoppel and explores…
DrugPatentWatch provides competitive intelligence on small-molecule drugs and the 90,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. ZEMPLAR (paricalcitol) Abbvie Patent number: 5,597,815 Expiration Date: Jan 13, 2016 For more information try a free trial
DrugPatentWatch now contains the most complete resources for pharmaceutical drug patents, expired and acrive, both in the United States and internationally. The most recent addition is the integration of drug patents dating back to the oldest records held by the US Food and Drug Administration. International equivalents for US patents are also available in more […]
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
ABSTRACT:
The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.
Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:
For more information, see the Journal of Commercial Biotechnology website